Research Article

Expression profiles of LMAN2 in breast cancer cell lines in hypoxia and normoxia conditions

Volume: 18 Number: 3 July 2, 2025
EN TR

Expression profiles of LMAN2 in breast cancer cell lines in hypoxia and normoxia conditions

Abstract

Abstract Purpose: Breast cancer is one of the most common and leading causes of death in women. The mechanism by which breast cancer develops is not fully understood. Understanding the mechanism of initiation and the genes and proteins involved in this process may help us to fight this type of cancer. The LMAN2 gene encodes VIP36, which transports properly folded proteins. The main aim of this study was to investigate the expression of the LMAN2 gene at the molecular level in breast cancer cells with different functional defects. Determining the level of LMAN2 gene expression under hypoxia, known as oxygen deprivation, has a significant impact on tumourigenesis and metastasis, and obtaining new data on the relationship between hypoxia and ER stress was identified as a secondary objective. Material and methods: In this study, the expression level of the LMAN2 gene will be examined in breast cancer cell lines (SKBR3, MDA-MB-231, MDA-MB-468, MCF-7) and CRL4010 cell line as a control. Results: LMAN2 gene expression level was evaluated at 48-hour periods by providing normoxic and hypoxic conditions. While the LMAN2 gene expression level in MCF-7, MDA-MB-231, and SK-BR-3 cells is significantly reduced, it was highly expressed in MDA-MB-468 in hypoxic and normoxic conditions. CHOP, HERP, and BiP gene expression levels were significantly higher in MDA-MB-468 under hypoxic conditions like LMAN2 expression. Conclusion: LMAN2 and other ER stress response elements showed different expression profiles in SK-BR-3, MDA-MB-231, MDA-MB-468, and MCF7 cell lines under hypoxic conditions. Increased expression was found in MCF-7 and MDA-MB-468 cell lines, but decreased expression was detected in SK-BR-3 and MDA-MB-231 cell lines. The underlying reason for this difference is thought to be that the cell lines have different molecular properties, such as triple negative or HER2 (+/-) status.

Keywords

Supporting Institution

Halic University Scientific Research Projects Unit

Project Number

HBAP604-II-3.

Ethical Statement

This study has been designed as an in vitro and worked on human cell lines. This study does not require ethics committee approval

Thanks

Dear Editor, We are submitting our manuscript entitled " Expression profiles of LMAN2 in breast cancer cell lines in hypoxia and normoxia conditions". This manuscript has not been published and is not being considered for publication or simultaneously submitted elsewhere. All the authors have read the manuscript and approved it. Our study does not bear any conflict. In our study, we performed gene expression analyses to observe the effect of hypoxia conditions on our target gene LMAN2. Together with this gene we evaluated the other ER stress-related genes and tried to understand the role of LMAN2 in ER stress. We found that the LMAN2 gene expression level in MCF-7, MDA-MB-231, and SK-BR-3 cells is significantly reduced, but it was highly expressed in MDA-MB-468 in both hypoxic and normoxic conditions. CHOP, HERP, and BiP gene expression levels were significantly higher in MDA-MB-468 under hypoxic conditions like LMAN2 expression. As a result, hypoxia causes an increase in LMAN2 expression in healthy breast epithelial cells. It might be a protein involved in the ER stress pathway. To support these interpretations, more in-depth research is required. With our best regards.

References

  1. 1. Banach A, Jiang YP, Roth E, Kuscu C, Cao J, Lin RZ. CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia. Oncotarget. 2019;10(42):4307-4320. Published 2019 Jul 2. doi:10.18632/oncotarget.27036
  2. 2. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48. doi:10.3322/caac.21763
  3. 3. Eliyatkın N, Yalçın E, Zengel B, Aktaş S, Vardar E. Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way. J Breast Health. 2015;11(2):59-66. Published 2015 Apr 1. doi:10.5152/tjbh.2015.1669
  4. 4. Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185. doi:10.1155/2014/149185
  5. 5. Bettencourt C, Foti SC, Miki Y, et al. White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy. Acta Neuropathol. 2020;139(1):135-156. doi:10.1007/s00401-019-02074-0
  6. 6. Davalieva K, Kiprijanovska S, Maleva Kostovska I, et al. Comparative Proteomics Analysis of Urine Reveals Down-Regulation of Acute Phase Response Signaling and LXR/RXR Activation Pathways in Prostate Cancer. Proteomes. 2017;6(1):1. Published 2017 Dec 29. doi:10.3390/proteomes6010001
  7. 7. Demiryürek AN, Göktürk Ö, Saracaloglu A, Demiryürek S, Demiryürek AT. Protective effects of verbenalin and (+)-eudesmin against 6-hydroxydopamine-induced oxidative/nitrosative stress in SH-SY5Y cells. Mol Biol Rep. 2023;50(1):331-338. doi:10.1007/s11033-022-08039-z
  8. 8. Maekawa H, Inagi R. Stress Signal Network between Hypoxia and ER Stress in Chronic Kidney Disease. Front Physiol. 2017;8:74. Published 2017 Feb 8. doi:10.3389/fphys.2017.00074

Details

Primary Language

English

Subjects

Biochemistry and Cell Biology (Other)

Journal Section

Research Article

Early Pub Date

January 13, 2025

Publication Date

July 2, 2025

Submission Date

August 16, 2024

Acceptance Date

January 13, 2025

Published in Issue

Year 2025 Volume: 18 Number: 3

APA
Okudu, C., Ağtürk, G., Kesim, E., & Ebrahımı, A. (2025). Expression profiles of LMAN2 in breast cancer cell lines in hypoxia and normoxia conditions. Pamukkale Medical Journal, 18(3), 474-485. https://doi.org/10.31362/patd.1533261
AMA
1.Okudu C, Ağtürk G, Kesim E, Ebrahımı A. Expression profiles of LMAN2 in breast cancer cell lines in hypoxia and normoxia conditions. Pam Med J. 2025;18(3):474-485. doi:10.31362/patd.1533261
Chicago
Okudu, Ceyda, Gökhan Ağtürk, Elif Kesim, and Ayyub Ebrahımı. 2025. “Expression Profiles of LMAN2 in Breast Cancer Cell Lines in Hypoxia and Normoxia Conditions”. Pamukkale Medical Journal 18 (3): 474-85. https://doi.org/10.31362/patd.1533261.
EndNote
Okudu C, Ağtürk G, Kesim E, Ebrahımı A (July 1, 2025) Expression profiles of LMAN2 in breast cancer cell lines in hypoxia and normoxia conditions. Pamukkale Medical Journal 18 3 474–485.
IEEE
[1]C. Okudu, G. Ağtürk, E. Kesim, and A. Ebrahımı, “Expression profiles of LMAN2 in breast cancer cell lines in hypoxia and normoxia conditions”, Pam Med J, vol. 18, no. 3, pp. 474–485, July 2025, doi: 10.31362/patd.1533261.
ISNAD
Okudu, Ceyda - Ağtürk, Gökhan - Kesim, Elif - Ebrahımı, Ayyub. “Expression Profiles of LMAN2 in Breast Cancer Cell Lines in Hypoxia and Normoxia Conditions”. Pamukkale Medical Journal 18/3 (July 1, 2025): 474-485. https://doi.org/10.31362/patd.1533261.
JAMA
1.Okudu C, Ağtürk G, Kesim E, Ebrahımı A. Expression profiles of LMAN2 in breast cancer cell lines in hypoxia and normoxia conditions. Pam Med J. 2025;18:474–485.
MLA
Okudu, Ceyda, et al. “Expression Profiles of LMAN2 in Breast Cancer Cell Lines in Hypoxia and Normoxia Conditions”. Pamukkale Medical Journal, vol. 18, no. 3, July 2025, pp. 474-85, doi:10.31362/patd.1533261.
Vancouver
1.Ceyda Okudu, Gökhan Ağtürk, Elif Kesim, Ayyub Ebrahımı. Expression profiles of LMAN2 in breast cancer cell lines in hypoxia and normoxia conditions. Pam Med J. 2025 Jul. 1;18(3):474-85. doi:10.31362/patd.1533261

Creative Commons Lisansı
Pamukkale Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License